295 related articles for article (PubMed ID: 12406866)
21. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
23. Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia.
Furuyama K; Kaneko K
Int J Hematol; 2018 Jan; 107(1):44-54. PubMed ID: 29139060
[TBL] [Abstract][Full Text] [Related]
24. Hereditary sideroblastic anemia: pathophysiology and gene mutations.
Harigae H; Furuyama K
Int J Hematol; 2010 Oct; 92(3):425-31. PubMed ID: 20848343
[TBL] [Abstract][Full Text] [Related]
25. Hypochromic red blood cells in low-risk myelodysplastic syndromes: effects of treatment with hemopoietic growth factors.
Ljung T; Bäck R; Hellström-Lindberg E
Haematologica; 2004 Dec; 89(12):1446-53. PubMed ID: 15590394
[TBL] [Abstract][Full Text] [Related]
26. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria.
Houwerzijl EJ; Pol HW; Blom NR; van der Want JJ; de Wolf JT; Vellenga E
Leukemia; 2009 May; 23(5):886-91. PubMed ID: 19148135
[TBL] [Abstract][Full Text] [Related]
27. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
28. [Molecular pathophysiology of sideroblastic anemia].
Fujiwara T
Rinsho Ketsueki; 2018; 59(10):1979-1987. PubMed ID: 30305500
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M; Malcovati L
Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
[TBL] [Abstract][Full Text] [Related]
30. [Biology of sideroblastic anemia].
Harigae H
Rinsho Ketsueki; 2017; 58(4):347-352. PubMed ID: 28484165
[TBL] [Abstract][Full Text] [Related]
31. Animal models for X-linked sideroblastic anemia.
Yamamoto M; Nakajima O
Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
[TBL] [Abstract][Full Text] [Related]
32. Immunocytochemical detection of ferritin in human bone marrow and peripheral blood cells using monoclonal antibodies specific for the H and L subunit.
Invernizzi R; Cazzola M; De Fazio P; Rosti V; Ruggeri G; Arosio P
Br J Haematol; 1990 Nov; 76(3):427-32. PubMed ID: 2261353
[TBL] [Abstract][Full Text] [Related]
33. Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis.
Caocci G; La Nasa G; Bain BJ
Am J Hematol; 2016 Oct; 91(10):1056. PubMed ID: 27301073
[No Abstract] [Full Text] [Related]
34. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
35. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.
Nakajima O; Okano S; Harada H; Kusaka T; Gao X; Hosoya T; Suzuki N; Takahashi S; Yamamoto M
Genes Cells; 2006 Jun; 11(6):685-700. PubMed ID: 16716198
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of genes related to iron and mitochondrial metabolism in refractory anemia with ring sideroblasts.
del Rey M; Benito R; Fontanillo C; Campos-Laborie FJ; Janusz K; Velasco-Hernández T; Abáigar M; Hernández M; Cuello R; Borrego D; Martín-Zanca D; De Las Rivas J; Mills KI; Hernández-Rivas JM
PLoS One; 2015; 10(5):e0126555. PubMed ID: 25955609
[TBL] [Abstract][Full Text] [Related]
37. Different pathophysiological mechanisms of intramitochondrial iron accumulation in acquired and congenital sideroblastic anemia caused by mitochondrial DNA deletion.
Matthes T; Rustin P; Trachsel H; Darbellay R; Costaridou S; Xaidara A; Rideau A; Beris P
Eur J Haematol; 2006 Aug; 77(2):169-74. PubMed ID: 16856911
[TBL] [Abstract][Full Text] [Related]
38. Serum ferritin in refractory anemias.
Solomon LR; Hillman RS; Finch CA
Acta Haematol; 1981; 66(1):1-5. PubMed ID: 6794292
[TBL] [Abstract][Full Text] [Related]
39. Erythroid precursor cells in primary acquired and secondary sideroblastic anemia.
Takaku F; Mizoguchi H; Suda T; Kubota K; Miura Y
Exp Hematol; 1980; 8 Suppl 8():225-34. PubMed ID: 6962069
[TBL] [Abstract][Full Text] [Related]
40. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
Bhatia P; Singh A; Hedge A
J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
